Detalhe da pesquisa
1.
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.
Lancet
; 403(10443): 2504-2519, 2024 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795716
2.
Bimekizumab versus Adalimumab in Plaque Psoriasis.
N Engl J Med
; 385(2): 130-141, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33891379
3.
Bimekizumab versus Secukinumab in Plaque Psoriasis.
N Engl J Med
; 385(2): 142-152, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33891380
4.
Bimekizumab safety in patients with moderate-to-severe plaque psoriasis: pooled data from up to 3â years of treatment in randomized phase III trials.
Br J Dermatol
; 190(4): 477-485, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950894
5.
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trials.
J Am Acad Dermatol
; 2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38447700
6.
Bimekizumab safety in moderate to severe plaque psoriasis: Rates of hepatic events and changes in liver parameters over 2 years in randomized phase 3/3b trials.
J Am Acad Dermatol
; 2024 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38588819
7.
Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and -independent effects by CDK6-specific PROTACs.
Blood
; 135(18): 1560-1573, 2020 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040545
8.
Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis.
J Drugs Dermatol
; 21(2): 162-171, 2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133113
9.
SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.
Haematologica
; 105(9): 2273-2285, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054052
10.
Bimekizumab versus Adalimumab in Plaque Psoriasis. Reply.
N Engl J Med
; 385(12): 1150, 2021 09 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34525294
11.
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial.
J Am Acad Dermatol
; 79(2): 277-286.e10, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29609013
12.
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2).
J Am Acad Dermatol
; 79(2): 302-314.e6, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29660421
13.
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT).
J Am Acad Dermatol
; 79(2): 266-276.e5, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29660425
14.
Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study.
Lancet
; 388(10061): 2763-2774, 2016 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863807
15.
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
Rheumatology (Oxford)
; 56(9): 1498-1509, 2017 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28498975
16.
Targeting deubiquitinase activity with a novel small-molecule inhibitor as therapy for B-cell malignancies.
Blood
; 125(23): 3588-97, 2015 Jun 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-25814533
17.
Palladium-Catalyzed Alkene Carboamination Reactions of Electron-Poor Nitrogen Nucleophiles.
Adv Synth Catal
; 357(10): 2339-2344, 2015 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26622222
18.
Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML.
Blood
; 120(7): 1473-84, 2012 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-22740448
19.
Assessment of BRCA1 and BRCA2 Germline Variant Data From Patients With Breast Cancer in a Real-World Data Registry.
JCO Clin Cancer Inform
; 8: e2300251, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709234
20.
Combined gene expression and DNA occupancy profiling as a strategy to identify therapeutic target(s) in t(8;21) acute myeloid leukemia.
Crit Rev Eukaryot Gene Expr
; 23(2): 103-13, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23582033